These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3729174)

  • 1. Endotracheal aminoglycosides in gram negative pneumonia. A preliminary report.
    Sorensen VJ; Horst HM; Obeid FN; Bivins BA
    Am Surg; 1986 Jul; 52(7):391-4. PubMed ID: 3729174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN; Micek ST; Reichley RM; Ritchie DJ
    Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.
    Vasilev K; Reshedko G; Orasan R; Sanchez M; Teras J; Babinchak T; Dukart G; Cooper A; Dartois N; Gandjini H; Orrico R; Ellis-Grosse E;
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i29-40. PubMed ID: 18684704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of empiric aztreonam and aminoglycoside regimens in the treatment of serious gram-negative lower respiratory infections.
    Bjornson HS; Ramirez-Ronda C; Saavedra S; Rivera-Vázquez CR; Liu C; Hinthorn DR
    Clin Ther; 1993; 15(1):65-78. PubMed ID: 8458056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute pneumonias caused by Gram-negative organisms].
    Lovesio C
    Rev Clin Esp; 1982 May; 165(3):145-51. PubMed ID: 7134526
    [No Abstract]   [Full Text] [Related]  

  • 6. Salvage treatment of pneumonia and initial treatment of tracheobronchitis caused by multidrug-resistant Gram-negative bacilli with inhaled polymyxin B.
    Pereira GH; Muller PR; Levin AS
    Diagn Microbiol Infect Dis; 2007 Jun; 58(2):235-40. PubMed ID: 17350201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pneumonia caused by gram-negative bacteria. Diagnostic and prognostic aspects].
    Sosnowski W; Pilarska-Machowicz A; Górnicka-Wilczyńska M; Babicz D; Siwińska S; Olechnowicz R
    Pneumonol Pol; 1984 Jun; 52(6):265-71. PubMed ID: 6483633
    [No Abstract]   [Full Text] [Related]  

  • 8. Strategy of antibiotic rotation: long-term effect on incidence and susceptibilities of Gram-negative bacilli responsible for ventilator-associated pneumonia.
    Gruson D; Hilbert G; Vargas F; Valentino R; Bui N; Pereyre S; Bebear C; Bebear CM; Gbikpi-Benissan G
    Crit Care Med; 2003 Jul; 31(7):1908-14. PubMed ID: 12847382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enterobacter pneumonia.
    Karnad A; Alvarez S; Berk SL
    South Med J; 1987 May; 80(5):601-4. PubMed ID: 3576272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local administration of polymyxins into the respiratory tract for the prevention and treatment of pulmonary infections in patients without cystic fibrosis.
    Falagas ME; Kasiakou SK
    Infection; 2007 Feb; 35(1):3-10. PubMed ID: 17297582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of ceftriaxone in urinary and respiratory tract infections].
    Papierkowski A; Pietraszek-Mamcarz J; Kozłowska T; Górnicka G; Emeryk A
    Pol Tyg Lek; 1990 Apr 2-9; 45(14-15):300-2. PubMed ID: 2235713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors and outcome of community-acquired pneumonia due to Gram-negative bacilli.
    Falguera M; Carratalà J; Ruiz-Gonzalez A; Garcia-Vidal C; Gazquez I; Dorca J; Gudiol F; Porcel JM
    Respirology; 2009 Jan; 14(1):105-11. PubMed ID: 18699803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumonia caused by gram-negative bacilli: an overview.
    Levison ME; Kaye D
    Rev Infect Dis; 1985; 7 Suppl 4():S656-65. PubMed ID: 3909320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
    Mars RL; Moles K; Pope K; Hargrove P
    Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjunctive aerosolized antibiotics for treatment of ventilator-associated pneumonia.
    Czosnowski QA; Wood GC; Magnotti LJ; Croce MA; Swanson JM; Boucher BA; Fabian TC
    Pharmacotherapy; 2009 Sep; 29(9):1054-60. PubMed ID: 19698010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.
    Burgess DS; Frei CR
    J Antimicrob Chemother; 2005 Nov; 56(5):893-8. PubMed ID: 16162664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pyocyanea pneumonia].
    Zhang XP; Deng K
    Zhonghua Jie He He Hu Xi Za Zhi; 1988 Apr; 11(2):111-4. PubMed ID: 3058341
    [No Abstract]   [Full Text] [Related]  

  • 19. Gram-negative meningitis and infections in individuals treated with intrathecal baclofen for spasticity: a retrospective study.
    Wunderlich CA; Krach LE
    Dev Med Child Neurol; 2006 Jun; 48(6):450-5. PubMed ID: 16700935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and economic evaluation of subsequent infection following intravenous ciprofloxacin or imipenem therapy in hospitalized patients with severe pneumonia.
    Caldwell JW; Singh S; Johnson RH
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():129-34. PubMed ID: 10225583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.